Harbin Medisan Pharmaceutical Co.,Ltd. Posted 1.8 Million Yuan Net Loss in First Quarter of 2022

Harbin Medisan Pharmaceutical Co.,Ltd. (哈尔滨三联药业股份有限公司) (002900.SZ) reported a net loss of 1.8 million yuan in the first quarter of 2022, reversing a net profit of 563.2 million yuan for the same period in the previous year.

Meanwhile, the company posted 256.7 million yuan in revenue, up 11.5% year-on-year.

At the end of the reporting period, it had 3.3 billion yuan in total assets and 1.2 billion yuan in total liabilities, with a liability-to-asset ratio of 35.4%.